Platform for a Technological Leap in Antibiotics
Keywords:Antimicrobial-resistant organisms, Gram-negative bacteria, Klebsiella pneumoniae, Multidrug-resistant strains, Pathogenesis of tuberculosis
AbstractNTN Swiss Biotech™ brings together the Swiss Biotech Association SBA, which is involved in regulatory, financial and legal issues, and biotechnet Switzerland, which is active in translational R&D, to provide a technology base for joint projects. Biotechnet aims to push promising domains by creating topic-oriented platforms that enable academia and industry to work together to produce R&D results of major importance to society and the economy. The first activity initiated by biotechnet is the Antibiotics Platform that has now been launched.
How to Cite
E. Heinzelmann, Chimia 2015, 69, 809, DOI: 10.2533/chimia.2015.809.
Columns, Conference Reports
Copyright (c) 2015 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.